Evidence map›Paper›PMID 42293161›Full record

ArticleFrontiers in microbiomes2026

Age-specific early-life gut microbiome associations with eczema and food allergies during early immune development.

Harold Nunez, Timothy J Straub, Nabeel Imam, David Goad, Noel T Mueller, Ruben A T Mars, Cheryl Sew Hoy, Trillitye Paullin, Kimberley V Sukhum

Abstract read
In one paragraph

Article in Frontiers in microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Harold NunezSeeding Inc., doing business as Tiny Health, Austin, TX, United States.
Timothy J StraubSeeding Inc., doing business as Tiny Health, Austin, TX, United States.
Nabeel ImamSeeding Inc., doing business as Tiny Health, Austin, TX, United States.
David GoadSeeding Inc., doing business as Tiny Health, Austin, TX, United States.
Noel T MuellerDepartment of Pediatrics, Section of Nutrition, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Ruben A T MarsSeeding Inc., doing business as Tiny Health, Austin, TX, United States.
Cheryl Sew HoySeeding Inc., doing business as Tiny Health, Austin, TX, United States.
Trillitye PaullinFree to Feed, Durham, NC, United States.
Kimberley V SukhumSeeding Inc., doing business as Tiny Health, Austin, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Eczema and food allergy commonly emerge during infancy and are linked to changes in the gut microbiome, yet it remains unclear when microbiome differences associated with allergic disease first appear during development. Methods: We analyzed age-stratified shotgun metagenomic data from 97 children aged 4-36 months, including physician-confirmed cases of eczema or food allergy and non-allergic controls, excluding recent antibiotic or probiotic exposure. Microbial taxa, functional pathways, and composite microbiome metrics were evaluated across three developmental stages: early infancy (4-6 months), mid-infancy (6-12 months), and toddlerhood (12-36 months). Results: Differences between allergic and non-allergic children were minimal before 6 months of age but became more apparent during mid-infancy and persisted into toddlerhood. Allergic conditions were associated with reduced abundance of fiber-fermenting and butyrate-producing taxa, enrichment of facultative and inflammation-associated microbes, lower microbiome maturation scores, and shifts in metabolic and inflammatory functional capacity. Discussion: These findings suggest that gut microbiome divergence associated with allergic disease becomes more apparent during mid-infancy, highlighting a developmentally relevant period for understanding early immune disruption. The results support further longitudinal and interventional studies aimed at clarifying whether earlier microbiome-targeted strategies may help modify progression along the atopic march.

Indexed as

atopic marcheczemafood allergiesgut microbiomeshort chain fatty acids

Identifiers

PMID42293161
PMCPMC13260514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.